ILARGIA: AI-based platform for de novo protein design and optimisation
Project fact sheet
ILARGIA
Vertical: Biotechnology
Project description
ILARGIA is based on an Artificial Intelligence ecosystem for protein design, applicable to both bioindustrial and medical uses. It offers stabilised variants of any natural protein, as well as de novo designed proteins, combining bioinformatics analysis with state-of-the-art AI-based structure and sequence design algorithms and, crucially, experimental validation in the laboratory. All this is possible thanks to the automation and integration of AI tools optimised for CIC bioGUNE’s high-performance computing cluster. Our methodology significantly reduces experimental work and costs, delivering high quality candidates directly from the simulations.
Market
Design of advanced proteins for biocatalysis, diagnostics and therapeutics, enabling high-precision regulation of biological processes. Creation of tailor-made biocatalysts that improve the efficiency, stability and speed of plastics recycling, reducing costs and promoting more sustainable industrial processes.
Financial needs: 600K over 3 years to cover technical and business staff costs
Technology tags
Business model
Project needs
Promoted by

Are you interested in high-tech projects capable of generating greater market impact?
Fill in this form and we will contact you if you want to take part in this initiative – either by contributing technology assets or if you are a talent promoter capable of turning them into business projects.
Related news

SAFEMOB: artificial intelligence for safer and more efficient public transport
Basque Tek Ventures backs this project that integrates AI in passenger vehicles to anticipate incidents and improve the travel experience

RECONNECT: spinal cord reconnection for people with spinal cord injuries
Basque Tek Ventures promotes this disruptive project that seeks to restore lost functions through state-of-the-art biocompatible implants

BEGI: on-chip 3D vision processor with back-end AI systems to enable neuromorphic DVS sensors
Basque Tek Ventures promotes this initiative to offer a new generation of three-dimensional perception in real time, more efficient and sustainable

Prospect Biotech: real-time analysis of cell cultures using light
Basque Tek Ventures is backing this project that offers an optic solution to develop and monitor advanced therapies.

Makby: 3D bioprinting software for regenerative medicine
Basque Tek Ventures is backing this initiative that will revolutionise the field of artificial biological tissues.

Konbus+: Controlled temperature and high velocity thermal spray systems
The initiative, coming under Basque Tek Ventures, provides high value-added coatings in extreme conditions in a cost-effective manner.

K-ALMA: Generative AI for reliable software tests
Basque Tek Ventures is backing this project that automates the code validations by reducing their high certification cost.

INTELLIWELD: assessment of weld quality
Basque Tek Ventures supports this initiative offering an integrated system to analyse and control process and product in welding systems.

FATRIXGEL: universal biomaterial for 3D cell cultures
The project, coming under Basque Tek Ventures, will revolutionise the generation of tissues to be used to research pharmaceutical and biotechnological therapies.

CRIOKEEP: device for the cryogenic storage, transport and dosing of therapeutic products
Basque Tek Ventures is backing this solution to improve the effectiveness of advanced medicine therapies by lowering risks and costs.